KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Receivables (2016 - 2026)

Staar Surgical (STAA) has disclosed Change in Receivables for 17 consecutive years, with -$9.8 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Change in Receivables rose 62.48% year-over-year to -$9.8 million, compared with a TTM value of -$27.8 million through Jan 2026, down 68.76%, and an annual FY2026 reading of -$27.8 million, down 68.76% over the prior year.
  • Change in Receivables was -$9.8 million for Q1 2026 at Staar Surgical, down from $25.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $31.2 million in Q2 2023 and bottomed at -$38.2 million in Q1 2025.
  • Average Change in Receivables over 5 years is $502125.0, with a median of $2.5 million recorded in 2022.
  • The sharpest move saw Change in Receivables surged 445.08% in 2022, then plummeted 2788.02% in 2024.
  • Year by year, Change in Receivables stood at $6.5 million in 2022, then plummeted by 372.23% to -$17.7 million in 2023, then tumbled by 48.2% to -$26.2 million in 2024, then soared by 198.7% to $25.9 million in 2025, then crashed by 138.02% to -$9.8 million in 2026.
  • Business Quant data shows Change in Receivables for STAA at -$9.8 million in Q1 2026, $25.9 million in Q3 2025, and -$5.7 million in Q2 2025.